Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 5 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
Holders of 5% or more of RPRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Royalty Pharma plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Legorreta Pablo G. | 13D/A | 18.73%101.8M shares | −1.01 ppfrom 19.74% | May 23, 20252 filings | Aug 17, 2026 | SEC |
| Morgan Stanley | 13G/A | 9.20%38.9M shares | – | Feb 9, 20216 filings | Aug 5, 2025 | SEC |
| Capital International Investors | 13G/A | 8.80%37.8M shares | +1.10 ppfrom 7.70% | Aug 13, 20254 filings | May 14, 2026 | SEC |
| FMR LLC | 13G/A | 6.50%27.9M shares | −2.60 ppfrom 9.10% | Feb 8, 20217 filings | Nov 5, 2025 | SEC |
| BlackRock, Inc. | 13G | 5.70%25.4M shares | New | Feb 4, 20251 filing | Feb 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
38 Schedule 13D and 13G filings on Royalty Pharma plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 20266:31 PM ET | Legorreta Pablo G.and 1 other | 13D/A | 18.73%101.8M shares | −1.01 ppfrom 19.74% | Aug 13, 2026 | SEC |
| Jun 16, 20264:30 PM ET | Severgnini Achille G.and 1 other | 13D/A | 4.80%21.4M shares | −0.90 ppfrom 5.70%Below 5% | Jun 12, 2026 | SEC |
| May 14, 202612:52 PM ET | Capital International Investors | 13G/A | 8.80%37.8M shares | +1.10 ppfrom 7.70% | Mar 31, 2026 | SEC |
| Feb 20, 20264:27 PM ET | Severgnini Achille G.and 1 other | 13D/A | 5.70%24.2M shares | −1.20 ppfrom 6.90% | Nov 6, 2025 | SEC |
| Feb 13, 20264:29 PM ET | Capital International Investors | 13G/A | 7.70%32.7M shares | +1.10 ppfrom 6.60% | Dec 31, 2025 | SEC |
| Nov 13, 202511:04 AM ET | Capital International Investors | 13G/A | 6.60%28.5M shares | +1.10 ppfrom 5.50% | Sep 30, 2025 | SEC |
| Nov 5, 202511:44 AM ET | FMR LLCand 1 other | 13G/A | 6.50%27.9M shares | −2.60 ppfrom 9.10% | Sep 30, 2025 | SEC |
| Oct 30, 20253:48 PM ET | Vanguard Group Inc | 13G/A | 2.52%10.9M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20258:30 AM ET | General Atlantic LLCand 18 others | 13G/A | 3.20%14.2M shares | –Below 5% | Jun 30, 2025 | SEC |
| Aug 13, 202512:49 PM ET | Capital International Investors | 13G | 5.50%23.1M shares | New | Jun 30, 2025 | SEC |
| Aug 5, 202511:56 AM ET | Morgan Stanleyand 1 other | 13G/A | 9.20%38.9M shares | – | Jun 30, 2025 | SEC |
| May 23, 20255:05 PM ET | Legorreta Pablo G.and 1 other | 13D | 19.74%103.1M shares | New | May 16, 2025 | SEC |
| May 12, 202510:39 AM ET | FMR LLCand 1 other | 13G/A | 9.10%39.2M shares | +3.20 ppfrom 5.90% | Mar 31, 2025 | SEC |
| May 2, 20256:19 PM ET | Severgnini Achille G.and 1 other | 13D/A | 6.90%29.9M shares | −1.40 ppfrom 8.30% | Apr 30, 2025 | SEC |
| Feb 21, 20254:30 PM ET | Severgnini Achille G.and 1 other | 13D/A | 8.30%36.0M shares | – | Feb 19, 2025 | SEC |
| Feb 12, 20259:30 AM ET | FMR LLCand 1 other | 13G/A | 5.90%26.3M shares | – | Dec 31, 2024 | SEC |
| Feb 4, 20253:45 PM ET | BlackRock, Inc. | 13G | 5.70%25.4M shares | New | Dec 31, 2024 | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | General Atlantic LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | General Atlantic LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Oct 4, 2022 | Giuliani Mario Germano | 13D/AOld format | – | – | – | SEC |
| Aug 11, 2022 | Giuliani Mario Germano | 13D/AOld format | – | – | – | SEC |
| Apr 5, 2022 | Giuliani Mario Germano | 13D/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | General Atlantic LLC | 13GOld format | – | New | – | SEC |
| Feb 11, 2021 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Royalty Pharma plc shares.
No Form 144 notices for Royalty Pharma plc are on file.